Question

What will be the vaccine efficacy of the two-dose Johnson & Johnson Ad26.COV2.S vaccine candidate according to the results of Phase III testing?

20 comments20

Total Forecasters32

Community Prediction89.8

Make a Prediction

This question is closed for predictions, and is waiting to be resolved

My Prediction

community

lower 25%

median

upper 75%

...

82.61

89.82

94.5

Authors:

juancambeiro

Opened:

Closed:

Scheduled resolution:

Phases of clinical research

Epidemiology

Why You Might Need Two COVID-19 Shots This Season

Time•Oct 29, 2024

Who is eligible for the mpox jab? As UK confirms first case of deadly new strain that can be transmitted through sex...everything you need to know

Daily Mail•Nov 1, 2024

A promising schizophrenia drug showed mixed results. What does that mean for patients?

Associated Press•Nov 4, 2024

Learn more about Metaculus NewsMatch

How many total SARS-CoV-2 mRNA vaccine doses will the US FDA and CDC recommend for at least 15% of the US on December 31, 2024?

Before June 2032, will the US FDA authorize a vaccine without phase III efficacy data in response to a new public health emergency?

Before 2032, will these pan-coronavirus vaccine candidates be approved by the USA, UK, EU, or Canada?

Comments

? comments